Clemson University has been accused of demolition by neglect of a building it wants to tear down at historic vegetable research farm in Charleston.

Ocugen (OCGN) is a clinical-stage biotech focused on modifier gene therapies for inherited retinal diseases, with key catalysts expected by 2026.

De-extinction. It’s not a word many of us were thinking about just a decade ago, but it’s one that we’re getting ever more familiar with. The de-extinction company Colossal Biosciences has set its ...